• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于粪便微生物群移植的厌氧粪便处理可提高专性厌氧菌的活力。

Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes.

作者信息

Bénard Mèlanie V, Arretxe Iñaki, Wortelboer Koen, Harmsen Hermie J M, Davids Mark, de Bruijn Clara M A, Benninga Marc A, Hugenholtz Floor, Herrema Hilde, Ponsioen Cyriel Y

机构信息

Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

出版信息

Microorganisms. 2023 Sep 5;11(9):2238. doi: 10.3390/microorganisms11092238.

DOI:10.3390/microorganisms11092238
PMID:37764082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10535047/
Abstract

Fecal microbiota transplantation (FMT) is under investigation for several indications, including ulcerative colitis (UC). The clinical success of FMT depends partly on the engraftment of viable bacteria. Because the vast majority of human gut microbiota consists of anaerobes, the currently used aerobic processing protocols of donor stool may diminish the bacterial viability of transplanted material. This study assessed the effect of four processing techniques for donor stool (i.e., anaerobic and aerobic, both direct processing and after temporary cool storage) on bacterial viability. By combining anaerobic culturing on customized media for anaerobes with 16S rRNA sequencing, we could successfully culture and identify the majority of the bacteria present in raw fecal suspensions. We show that direct anaerobic processing of donor stool is superior to aerobic processing conditions for preserving the bacterial viability of obligate anaerobes and butyrate-producing bacteria related to the clinical response to FMT in ulcerative colitis patients, including , , and . The effect of oxygen exposure during stool processing decreased when the samples were stored long-term. Our results confirm the importance of sample conditioning to preserve the bacterial viability of oxygen-sensitive gut bacteria. Anaerobic processing of donor stool may lead to increased clinical success of FMT, which should further be investigated in clinical trials.

摘要

粪便微生物群移植(FMT)正在针对多种适应症进行研究,包括溃疡性结肠炎(UC)。FMT的临床成功部分取决于活细菌的植入。由于绝大多数人类肠道微生物群由厌氧菌组成,目前使用的供体粪便需氧处理方案可能会降低移植材料的细菌活力。本研究评估了供体粪便的四种处理技术(即厌氧和需氧,包括直接处理和临时冷藏后处理)对细菌活力的影响。通过将定制的厌氧菌培养基上的厌氧培养与16S rRNA测序相结合,我们能够成功培养并鉴定出原始粪便悬液中存在的大多数细菌。我们表明,对于保存与溃疡性结肠炎患者FMT临床反应相关的专性厌氧菌和产丁酸细菌的细菌活力,供体粪便的直接厌氧处理优于需氧处理条件,包括[具体细菌名称1]、[具体细菌名称2]和[具体细菌名称3]。当样本长期储存时,粪便处理过程中氧气暴露的影响会降低。我们的结果证实了样本处理对于保存对氧敏感的肠道细菌的细菌活力的重要性。供体粪便的厌氧处理可能会提高FMT的临床成功率,这一点应在临床试验中进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/2dafb302e795/microorganisms-11-02238-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/77f1ea2afb60/microorganisms-11-02238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/f6487ce6d93f/microorganisms-11-02238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/571fae960e02/microorganisms-11-02238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/2dafb302e795/microorganisms-11-02238-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/77f1ea2afb60/microorganisms-11-02238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/f6487ce6d93f/microorganisms-11-02238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/571fae960e02/microorganisms-11-02238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/2dafb302e795/microorganisms-11-02238-g004.jpg

相似文献

1
Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes.用于粪便微生物群移植的厌氧粪便处理可提高专性厌氧菌的活力。
Microorganisms. 2023 Sep 5;11(9):2238. doi: 10.3390/microorganisms11092238.
2
Stool preparation under anaerobic conditions contributes to retention of obligate anaerobes: potential improvement for fecal microbiota transplantation.在厌氧条件下进行粪便准备有助于保留专性厌氧菌:改善粪便微生物群移植的潜力。
BMC Microbiol. 2021 Oct 9;21(1):275. doi: 10.1186/s12866-021-02325-9.
3
A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process.一种用于粪菌移植治疗溃疡性结肠炎的供体选择匹配策略:荟萃分析和层次分析法。
Microbiol Spectr. 2023 Feb 14;11(1):e0215921. doi: 10.1128/spectrum.02159-21. Epub 2022 Dec 6.
4
Shifts and importance of viable bacteria in treatment of DSS-induced ulcerative colitis mice with FMT.粪便微生物移植治疗 DSS 诱导的溃疡性结肠炎小鼠中存活细菌的转移和重要性。
Front Cell Infect Microbiol. 2023 Feb 6;13:1124256. doi: 10.3389/fcimb.2023.1124256. eCollection 2023.
5
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.与溃疡性结肠炎患者对粪便微生物群移植的反应相关的特定细菌和代谢物。
Gastroenterology. 2019 Apr;156(5):1440-1454.e2. doi: 10.1053/j.gastro.2018.12.001. Epub 2018 Dec 6.
6
Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation.粪便微生物群移植后溃疡性结肠炎中丁酸与肠道微生物群的相互作用
Front Microbiol. 2021 Apr 12;12:658292. doi: 10.3389/fmicb.2021.658292. eCollection 2021.
7
Bacterial viability in faecal transplants: Which bacteria survive?粪便移植中细菌的存活情况:哪些细菌能够存活?
EBioMedicine. 2019 Mar;41:509-516. doi: 10.1016/j.ebiom.2019.02.023. Epub 2019 Feb 19.
8
Evaluation of Bacterial Viability for Fecal Microbiota Transplantation: Impact of Thawing Temperature and Storage Time.粪便微生物群移植中细菌活力的评估:解冻温度和储存时间的影响
Microorganisms. 2024 Jun 25;12(7):1294. doi: 10.3390/microorganisms12071294.
9
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.复发性艰难梭菌感染和/或溃疡性结肠炎患者单次供体粪便微生物群移植的纵向微生物组分析
PLoS One. 2018 Jan 31;13(1):e0190997. doi: 10.1371/journal.pone.0190997. eCollection 2018.
10
Effects of Different Treatment of Fecal Microbiota Transplantation Techniques on Treatment of Ulcerative Colitis in Rats.不同粪菌移植技术处理对大鼠溃疡性结肠炎治疗效果的影响
Front Microbiol. 2021 Jul 14;12:683234. doi: 10.3389/fmicb.2021.683234. eCollection 2021.

引用本文的文献

1
Stunting is associated with persistent and transferable alterations in the gut microbiome.发育迟缓与肠道微生物群的持续且可转移的改变有关。
Gut Pathog. 2025 Jun 25;17(1):49. doi: 10.1186/s13099-025-00723-2.
2
Faecal microbiota transplantation in Crohn's disease: an Australian randomised placebo-controlled trial protocol.粪菌移植治疗克罗恩病:一项澳大利亚随机安慰剂对照试验方案
BMJ Open. 2025 Apr 19;15(4):e094714. doi: 10.1136/bmjopen-2024-094714.
3
Impact of Fecal Microbiota Transplant Formulations, Storage Conditions, and Duration on Bacterial Viability, Functionality, and Clinical Outcomes in Patients with Recurrent Infection.

本文引用的文献

1
Challenges and costs of donor screening for fecal microbiota transplantations.粪便微生物移植供体筛查的挑战和成本。
PLoS One. 2022 Oct 20;17(10):e0276323. doi: 10.1371/journal.pone.0276323. eCollection 2022.
2
Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.经口及胶囊粪便微生物群移植治疗复发性艰难梭菌感染的疗效和安全性。
Clin Gastroenterol Hepatol. 2023 May;21(5):1330-1337.e2. doi: 10.1016/j.cgh.2022.09.008. Epub 2022 Sep 17.
3
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
粪便微生物群移植制剂、储存条件和持续时间对复发性感染患者细菌活力、功能及临床结局的影响
Microorganisms. 2025 Mar 4;13(3):587. doi: 10.3390/microorganisms13030587.
4
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights.炎症性肠病中的微生物群移植疗法:进展与机制洞察
Gut Microbes. 2025 Dec;17(1):2477255. doi: 10.1080/19490976.2025.2477255. Epub 2025 Mar 10.
5
In vitro validation concept for lyophilized fecal microbiota products with a focus on bacterial viability.以细菌活力为重点的冻干粪便微生物群产品的体外验证概念。
World J Microbiol Biotechnol. 2025 Feb 27;41(3):83. doi: 10.1007/s11274-025-04291-0.
6
Multi-Omics Analysis Unravels the Impact of Stool Sample Logistics on Metabolites and Microbial Composition.多组学分析揭示粪便样本物流对代谢物和微生物组成的影响。
Microorganisms. 2024 Sep 30;12(10):1998. doi: 10.3390/microorganisms12101998.
7
Evaluating Bacterial Viability in Faecal Microbiota Transplantation: A Comparative Analysis of In Vitro Cultivation and Membrane Integrity Methods.评估粪便微生物群移植中的细菌活力:体外培养与膜完整性方法的比较分析。
J Clin Lab Anal. 2024 Oct;38(19-20):e25105. doi: 10.1002/jcla.25105. Epub 2024 Oct 3.
8
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments.通过噬菌体介导的治疗方法克服粪便微生物群移植相关的供体变异性和风险。
Microbiome. 2024 Jul 1;12(1):119. doi: 10.1186/s40168-024-01820-1.
9
Fecal microbiota transplantation: current challenges and future landscapes.粪便微生物群移植:当前的挑战和未来的前景。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0006022. doi: 10.1128/cmr.00060-22. Epub 2024 May 8.
10
Current perspectives on fecal microbiota transplantation in inflammatory bowel disease.炎症性肠病中粪便微生物群移植的当前观点
Indian J Gastroenterol. 2024 Feb;43(1):129-144. doi: 10.1007/s12664-023-01516-8. Epub 2024 Feb 9.
不同疾病的粪便微生物群移植后定植的菌株变异性和微生物组组成的可预测性。
Nat Med. 2022 Sep;28(9):1913-1923. doi: 10.1038/s41591-022-01964-3. Epub 2022 Sep 15.
4
Drivers and determinants of strain dynamics following fecal microbiota transplantation.粪便微生物群移植后菌株动态的驱动因素和决定因素。
Nat Med. 2022 Sep;28(9):1902-1912. doi: 10.1038/s41591-022-01913-0. Epub 2022 Sep 15.
5
Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial.粪菌移植联合抗炎饮食(FMT-AID)继之以单纯抗炎饮食在诱导和维持轻中度溃疡性结肠炎缓解方面有效:一项随机对照试验。
Gut. 2022 Dec;71(12):2401-2413. doi: 10.1136/gutjnl-2022-327811. Epub 2022 Aug 16.
6
Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis.溃疡性结肠炎患者粪菌移植应答的供体和受体预测生物标志物的系统评价。
EBioMedicine. 2022 Jul;81:104088. doi: 10.1016/j.ebiom.2022.104088. Epub 2022 May 31.
7
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.冻干口服粪便微生物群移植治疗溃疡性结肠炎(LOTUS):一项随机、双盲、安慰剂对照试验。
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):141-151. doi: 10.1016/S2468-1253(21)00400-3. Epub 2021 Dec 2.
8
Stool preparation under anaerobic conditions contributes to retention of obligate anaerobes: potential improvement for fecal microbiota transplantation.在厌氧条件下进行粪便准备有助于保留专性厌氧菌:改善粪便微生物群移植的潜力。
BMC Microbiol. 2021 Oct 9;21(1):275. doi: 10.1186/s12866-021-02325-9.
9
When anaerobes encounter oxygen: mechanisms of oxygen toxicity, tolerance and defence.当厌氧菌遇到氧气时:氧气毒性、耐受性和防御机制。
Nat Rev Microbiol. 2021 Dec;19(12):774-785. doi: 10.1038/s41579-021-00583-y. Epub 2021 Jun 28.
10
Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future?人类代谢性疾病中的粪便微生物群移植:从模糊的过去走向光明的未来?
Cell Metab. 2021 Jun 1;33(6):1098-1110. doi: 10.1016/j.cmet.2021.05.005.